Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology | Hepatology (Liver, Pancreatic, Gall Bladder) | Infections and Infectious Diseases | Vaccines

Hepatitis Clinical Trials

A listing of Hepatitis medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last 

Alabama

University of Alabama at Birmingham
Birmingham Alabama 35294

A Phase 2 clinical study for patients with Acute on Chronic Hepatic Failure, Acute Liver Failure, Liver Cirrhosis or Acute Alcoholic Hepatitis

Site Reference ID/Investigator# 95592
Birmingham Alabama 35294

A Phase 3 clinical study for patients with Hepatitis C, HIV Infection, Chronic Hepatitis C or Compensated Cirrhosis and Non-cirrhotics

Call for Information (Investigational Site 0413)
Birmingham Alabama 35294

Patients are needed to participate in a clinical research study evaluating MK-5172 100mg/MK-8742 50 mg fixed-dose combination and Placebo to MK-5172 + MK-8742 fixed-dose combination for the treatment of Chronic Hepatitis C Virus

Site Reference ID/Investigator# 103551
Birmingham Alabama 35215

Patients are needed to participate in a clinical research study of ABT-450/ritonavir, ABT-333 and ABT-267 to evaluate Hepatitis C

Clinical Research Advantage, Inc.
Birmingham Alabama 35211

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

View More »

Site Reference ID/Investigator# 124035
Dothan Alabama 36305

A clinical trial to evaluate treatments using ABT-450/r, ABT-530 and Ribavirin (RBV) for patients with Chronic Hepatitis C or Hepatitis C Virus

Site Reference ID/Investigator# 103531
Dothan Alabama 36305

Patients are needed to participate in a clinical research study of ABT-450/ritonavir, ABT-333 and ABT-267 to evaluate Hepatitis C

Arizona

Radiant Research
Chandler Arizona 85224

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Clinical Research Advantage, Inc.
Chandler Arizona 85224

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Clinical Research Advantage, Inc.
Glendale Arizona 85306

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Clinical Research Advantage, Inc.
Mesa Arizona 85213

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Clinical Research Advantage, Inc.
Mesa Arizona 85206

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

View More »

Phoenix Arizona
Updated

A clinical research study of SOF/GS-5816 and RBV for the treatment of Hepatitis C Virus Infection

Maricopa Integrated Health System (MIHS)
Phoenix Arizona 85008
Updated

A clinical trial to evaluate treatments using ELAD treatment and Standard of care (Control) for patients with Acute Alcoholic Hepatitis

Phoenix Arizona

A clinical trial to evaluate treatments using Telaprevir, Peginterferon alfa-2b and Ribavirin for patients with Hepatitis C

Spectrum Medical Group
Phoenix Arizona 85012

A Phase 3 clinical study for patients with HIV or HBV

Phoenix Children's Hospital
Phoenix Arizona 85016

Patients are needed to participate in a clinical research study evaluating Tenofovir DF and Tenofovir DF Placebo for the treatment of Chronic Hepatitis B Infection

Site Reference ID/Investigator# 106155
Phoenix Arizona 85054

Patients are needed to participate in a clinical research study of ABT-450/ritonavir, ABT-333 and ABT-267 to evaluate Hepatitis C

Phoenix Arizona

Patients are needed to participate in a clinical research study of No intervention to evaluate Hepatitis C Virus

Clinical Research Advantage, Inc.
Phoenix Arizona 85050

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Clinical Research Advantage, Inc.
Phoenix Arizona 85018

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Clinical Research Advantage, Inc.
Phoenix Arizona 85020

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Radiant Research
Scottsdale Arizona 85251

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Clinical Research Advantage, Inc.
Tempe Arizona 85283

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

University of Arizona Medical Center
Tucson Arizona 85724
Updated

A clinical trial to evaluate treatments using ELAD treatment and Standard of care (Control) for patients with Acute Alcoholic Hepatitis

Site Reference ID/Investigator# 95581
Tucson Arizona 85724-5136

A Phase 3 clinical study for patients with Hepatitis C, HIV Infection, Chronic Hepatitis C or Compensated Cirrhosis and Non-cirrhotics

Site Reference ID/Investigator# 106055
Tucson Arizona 85724

Patients are needed to participate in a clinical research study of ABT-450/ritonavir, ABT-333 and ABT-267 to evaluate Hepatitis C

Radiant Research
Tucson Arizona 85712

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Clinical Research Advantage, Inc.
Tucson Arizona 85741

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

GSK Investigational Site
Tucson Arizona 85741

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Arkansas

GSK Investigational Site
Fayetteville Arkansas 72703

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

University of Arkansas for Medical Sciences
Little Rock Arkansas 72205
Updated

A clinical trial to evaluate treatments using ELAD treatment and Standard of care (Control) for patients with Acute Alcoholic Hepatitis

California

Anaheim Clinical Trials (ACT)
Anaheim California 92801

Hepatitis C research study for Latino and non-Latino patients who are treatment Naïve.

View More »

GSK Investigational Site
Anaheim California 92804

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Novartis Investigative Site
Bakersfield California 93301

A clinical research study of DEB025 and RBV for the treatment of Hepatitis C, Liver Disease

Site Reference ID/Investigator# 126569
Bakersfield California 93301

Patients are needed to participate in a clinical research study evaluating ABT-450/r/ABT-267, ABT-333 and Ribavirin (RBV) for the treatment of Chronic Hepatitis C Virus (HCV) Infection Genotype 1

Site Reference ID/Investigator# 103524
Bakersfield California 93301

Patients are needed to participate in a clinical research study of ABT-450/ritonavir, ABT-333 and ABT-267 to evaluate Hepatitis C

Franco Felizarta, MD
Bakersfield California 93301

Patients are needed to participate in a clinical research study to evaluate Hepatitis C

Site Reference ID/Investigator# 95580
Beverly Hills California 90211

A Phase 3 clinical study for patients with Hepatitis C, HIV Infection, Chronic Hepatitis C or Compensated Cirrhosis and Non-cirrhotics

AHF Research Center
Beverly Hills California 90211

A Phase 3 clinical study for patients with HIV or HBV

Beverly Hills California

Patients are needed to participate in a clinical research study of No intervention to evaluate Hepatitis C Virus

Sharp Coronado Hospital
Coronado California 92118
Updated

A clinical trial to evaluate treatments using ELAD treatment and Standard of care (Control) for patients with Acute Alcoholic Hepatitis

Site Reference ID/Investigator# 103530
Coronado California 92118

Patients are needed to participate in a clinical research study of ABT-450/ritonavir, ABT-333 and ABT-267 to evaluate Hepatitis C

Costa Mesa California

Patients are needed to participate in a clinical research study of GS-9857 and Placebo to match GS-9857 to evaluate Hepatitis C Virus Infection

GSK Investigational Site
Daly City California 94015

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

GSK Investigational Site
Fresno California 93726

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Advanced Rx Clinical Research
Garden Grove California 92843

Patients are needed to participate in a clinical research study for the treatment of Hepatitis B, Chronic

GSK Investigational Site
Hayward California 94545

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Scripps Clinic
La Jolla California 92037

A Phase 2 clinical study for patients with Acute on Chronic Hepatic Failure, Acute Liver Failure, Liver Cirrhosis or Acute Alcoholic Hepatitis

Site Reference ID/Investigator# 108867
La Jolla California 92037

Patients are needed to participate in a clinical research study of ABT-450/ritonavir, ABT-333 and ABT-267 to evaluate Hepatitis C

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last